ArticleMedical oncology (Northwood, London, England)2024

The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology.

Mark P van Opijnen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.